ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Ilexoside K Ameliorates Atherosclerosis by Suppressing CD72
Xingling He, Sijing Li, Jiahui Chen, Liyu Lin, Xinyu Li, Xiaojiao Zhang, Yihui Zhang, Xingling Chen, Jinjian Guo, Zhongqi Yang and 2 more
Abstract read
In one paragraphArticle in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Sijing Li *State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Jiahui Chen *State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiaojiao ZhangState Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Yihui ZhangState Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Xingling ChenState Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Jinjian GuoThe Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Zhongqi YangState Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Shihao NiState Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Funding
Fujian Province Young Scientific and Technological Talent Development Program 2026350685General Program of Natural Science Fund from Guangdong Provincial Basic and Applied Basic Research Foundation 2026A1515012409Guangdong Medical Science and Technology Research Fund B2025119Guangzhou Key R&D Program 2024B03J1298Guangzhou University of Chinese Medicine GZY2025GB0104Inheritance Studio of Guangdong Provincial Famous TCM PhysicianKey National Research and Development Program Project 2025YFC3507902National Natural Science Foundation of China 82505436State Key Laboratory of Traditional Chinese MedicineSyndrome "Open bidding for selecting the best candidates" Key Research Projects SKLKY2025C0013Young Talent Support Project of Guangzhou Association for Science and Technology QT-2025-037
6 · The paper itselfAbstract
Atherosclerotic cardiovascular disease (ASCVD) remains the leading global cause of mortality, with substantial residual inflammatory risk persisting despite statin therapy. We identify a c-Rel-driven CD72
Indexed as
atherosclerosisCD72hi macrophagesCXCL12‐CXCR4 axisendothelial pyroptosisIlexoside Kvascular inflammation
Identifiers
PMID42801532
PMCPMC13616409
What Socratic holds
Textmetadata
Read underepoch 390